http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-20110018-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55428b3722bb214f73cfc086284839c2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e65921f666b69731071cc887b40c7f7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df00781ddd3d912b3dea3f5610c09720
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080490670eb8394a37aa382e46954049
publicationDate 2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RS-20110018-A2
titleOfInvention COMBINED TABLET FORM AND PROCEDURES FOR ITS OBTAINING IT
abstract The present invention relates to a novel combination tablet formulation containing four active components such as paracetamol 35 to 45% w / w total tablet weight, propyphenazone 25-37% w / w total tablet weight, codeine phosphate 1.1 to 1 , 9% w / w total tablet weight and caffeine 5-9% w / w total tablet weight as well as the procedures for obtaining it.
priorityDate 2010-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448487131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597

Total number of triples: 24.